Taken together, these results support the hypothesis that the HIF1α/PFKFB3 stress/repair pathway is activated by hIAPP toxicity, and is also activated in β-cells in humans with T2D. The gene discussed is PFKFB3; the disease is type 2 diabetes mellitus.